Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) are the third most commonly prescribed group of drugs in Spain. We present here the profile of adverse drug reactions (ADRs) attributed to them and reported to the Spanish System of Pharmacovigilance (SSPV) between 1983 and 1991, together with a preliminary analysis of topical, slow-release (SR) and enteric-coated (EC) preparations.
Out of 18 348 reports of ADRs included in the SSPV database, 1609 (8.8%) implicated an NSAID. NSAIDs ranked second after antibiotics (15.1% of all reports) among the most commonly implicated drugs. Half of the patients were more than 55 years old, and 60% were women.
Diclofenac (364 reports), piroxicam (282), indomethacin (197), naproxen (155), and ketoprofen (137) were the most commonly implicated NSAIDs in reports of ADRs.
The most commonly reported ADRs were gastrointestinal (39%), cutaneous (20%), and those affecting the central and peripheral nervous system (9%). Seven reactions had a fatal outcome, and 138 were considered life threatening. Forty-nine reports included previously undescribed ADRs.
There were 98 reports describing ADRs attributed to topical NSAIDs; 5 of these described 11 general reactions, such as duodenal ulcer, gastrointestinal bleeding, diarrhoea, dyspnoea, facial oedema, aggravation of bronchospasm, and angioedema.
One hundred and sixty-eight reports referred to SR and EC preparations. The ratio of gastrointestinal to non-gastrointestinal reactions to SR-EC diclofenac was higher in the case of SR-EC diclofenac than in the case of plain diclofenac (P=0.037); similarly, the ratio of CNS to non-CNS reactions to SR-EC indomethacin was also higher than the corresponding ratio with plain indomethacin (P=0.002). Although differential selective reporting of these preparations cannot be excluded, these results raise doubts about the relative safety of SR and EC preparations of NSAIDs in practice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brune K, Schweitzer A, Lanz R (1984) Importance of drug biodistribution and metabolism in the development of side-effects by antiinflammatory/analgesic drugs. In: Rainsford KD, Velo GP (eds) Advances in inflammation research, 6th edn. Raven Press, New York, pp 35–42
Anonymous (1993) Evolución de los 10 subgrupos terapéuticos más consumidos. Indic Presc Farm Insalud 11: 51–59
Rainsford KD (1984) Side-effects of anti-inflammatory/analgesic drugs: epidemiology and gastrointestinal tract. Trends Pharmacol Sci 5:156–159
Weber JCP (1984) Epidemiology of adverse reactions to non-steroidal anti-inflammatory drugs. In: Rainsford KD, Velo GP (eds) Advances in inflammation research, 6th edn. Raven Press, New York, pp 1–7
Adams SS (1988) NSAIDs, plasma half-lives, and adverse reactions. Lancet 1:653–654
Laporte JR (1986) Spain. In: Inman WHW (ed) Monitoring for drug safety, 2nd edn. MTP Press, Lancaster, pp 143–152
Laporte JR, Capellà D (1985) El desarrollo de la farmacovigilancia en España. Inf Ter Segur Soc 9:129–135
Armadans L, Carné X, Laporte JR (1988) Detección de reacciones adversas a medicamentos a partir del diagnóstico de ingreso hospitalario: método y resultados. Med Clin (Barc) 91:124–127
Ibáñez L, Laporte JR, Carné X (1991) Adverse drug reactions leading to hospital admission. Drug Saf 6:450–459
The International Agranulocytosis and Aplastic Anemia Study (1983) The design of a study on the drug etiology of agranulocytosis and aplastic anemia. Eur J Clin Pharmacol 24:833–836
The International Agranulocytosis and Aplastic Anemia Study (1986) Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. JAMA 256:1749–1757
Consejo General de Colegios Oficiales de Farmacéuticos (1990) Catálogo de especialidades farmacéuticas. Einsa, Madrid
Baum C, Kennedy DL, Forbes MB (1985) Utilization of non-steroidal antiinflammatory drugs. Arthritis Rheum 28:686–692
Leufkens HG, Ruter EM, Ameling CB, Hekster YA, Bakker A (1991) Linkage of pharmacy data on heavy users of non-steroidal anti-inflammatory drugs to information from general practitioners. J Pharmacoepidemiol 2:67–77
Walker AM, Chan K-WA, Yood RA (1992) Patterns of interchange in the dispensing of non-steroidal anti-inflammatory drugs. J Clin Epidemiol 45:187–195
Laporte JR, Carné X, Vidal X, Moreno V, Juan J (1991) Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet 337:85–89
Anonymous (1990) More topical NSAIDs: worth the rub? Drug Ther Bull 28:27–28
Radermacher J, Jentsch D, Scholl MA, Lustinetz T, Frölich JC (1991) Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 31:537–541
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Figueras, A., Capellà, D., Castel, J.M. et al. Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol 47, 297–303 (1994). https://doi.org/10.1007/BF00191158
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00191158